{"id":"https://openalex.org/W2075569986","doi":"https://doi.org/10.1016/s0960-894x(01)00029-4","title":"Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core","display_name":"Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core","publication_year":2001,"publication_date":"2001-03-01","ids":{"openalex":"https://openalex.org/W2075569986","doi":"https://doi.org/10.1016/s0960-894x(01)00029-4","mag":"2075569986","pmid":"https://pubmed.ncbi.nlm.nih.gov/11266160"},"language":"en","primary_location":{"id":"doi:10.1016/s0960-894x(01)00029-4","doi":"https://doi.org/10.1016/s0960-894x(01)00029-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0960-894x(01)00029-4","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073451654","display_name":"John M. Fevig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John M. Fevig","raw_affiliation_strings":["DuPont Pharmaceuticals Company, Wilmington, DE 19880-0500, USA. john.m.fevig@dupontpharma.com","DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DuPont Pharmaceuticals Company, Wilmington, DE 19880-0500, USA. john.m.fevig@dupontpharma.com","institution_ids":["https://openalex.org/I1316910977"]},{"raw_affiliation_string":"DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062012797","display_name":"Donald J. P. Pinto","orcid":"https://orcid.org/0000-0003-4356-5979","observed_orcids":["https://orcid.org/0000-0003-4356-5979"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Donald J. Pinto","raw_affiliation_strings":["DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101927599","display_name":"Qi Han","orcid":"https://orcid.org/0000-0002-9418-807X","observed_orcids":["https://orcid.org/0000-0002-9418-807X"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qi Han","raw_affiliation_strings":["DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030883249","display_name":"Mimi L. C. Quan","orcid":"https://orcid.org/0000-0001-5866-0114","observed_orcids":["https://orcid.org/0000-0001-5866-0114"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mimi L. Quan","raw_affiliation_strings":["DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082976193","display_name":"James R. Pruitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James R. Pruitt","raw_affiliation_strings":["DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008185004","display_name":"Irina C. Jacobson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irina C. Jacobson","raw_affiliation_strings":["DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044117839","display_name":"Robert A. Galemmo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. Galemmo, Jr","raw_affiliation_strings":["DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073159270","display_name":"Shuaige Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shuaige Wang","raw_affiliation_strings":["DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073152979","display_name":"Michael J. Orwat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Orwat","raw_affiliation_strings":["DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033292728","display_name":"Lori L. Bostrom","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lori L. Bostrom","raw_affiliation_strings":["DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084860922","display_name":"Robert M. Knabb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert M. Knabb","raw_affiliation_strings":["DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026904604","display_name":"Pancras C. Wong","orcid":"https://orcid.org/0000-0002-8224-7423","observed_orcids":["https://orcid.org/0000-0002-8224-7423"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pancras C. Wong","raw_affiliation_strings":["DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055224019","display_name":"Patrick Y. S. Lam","orcid":"https://orcid.org/0000-0001-7113-2594","observed_orcids":["https://orcid.org/0000-0001-7113-2594"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Y.S. Lam","raw_affiliation_strings":["DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003421053","display_name":"Ruth R. Wexler","orcid":"https://orcid.org/0000-0001-5514-5053","observed_orcids":["https://orcid.org/0000-0001-5514-5053"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruth R. Wexler","raw_affiliation_strings":["DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, DE 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5062012797","https://openalex.org/A5073451654"],"corresponding_institution_ids":["https://openalex.org/I1316910977"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":1.746,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.84820962,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"11","issue":"5","first_page":"641","last_page":"645"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.030799999833106995,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/factor-xa-inhibitors","display_name":"factor Xa inhibitors","score":0.9629999995231628},{"id":"https://openalex.org/keywords/benzamidine","display_name":"benzamidine","score":0.8939999938011169},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8029999732971191},{"id":"https://openalex.org/keywords/antithrombotic-agents","display_name":"antithrombotic agents","score":0.9629999995231628},{"id":"https://openalex.org/keywords/coagulation-factor-xa","display_name":"coagulation factor Xa","score":0.7099999785423279},{"id":"https://openalex.org/keywords/thrombin-inhibitors","display_name":"thrombin inhibitors","score":0.4000000059604645},{"id":"https://openalex.org/keywords/drug-synthesis","display_name":"drug synthesis","score":0.3269999921321869}],"concepts":[{"id":"https://openalex.org/C2779288520","wikidata":"https://www.wikidata.org/wiki/Q4890748","display_name":"Benzamidine","level":3,"score":0.9891263246536255},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9026696681976318},{"id":"https://openalex.org/C2777015399","wikidata":"https://www.wikidata.org/wiki/Q4775337","display_name":"Antithrombotic","level":2,"score":0.7104705572128296},{"id":"https://openalex.org/C2778622868","wikidata":"https://www.wikidata.org/wiki/Q423088","display_name":"Amidine","level":2,"score":0.704348623752594},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5141101479530334},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.4823564887046814},{"id":"https://openalex.org/C57002609","wikidata":"https://www.wikidata.org/wiki/Q5281999","display_name":"Discovery and development of direct thrombin inhibitors","level":4,"score":0.46881699562072754},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.46363040804862976},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.4463125467300415},{"id":"https://openalex.org/C2164484","wikidata":"https://www.wikidata.org/wiki/Q5170150","display_name":"Core (optical fiber)","level":2,"score":0.4310321509838104},{"id":"https://openalex.org/C2777292125","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin","level":3,"score":0.2512510418891907},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2133520245552063},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.20309343934059143},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.0},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.0},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.0},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001550","descriptor_name":"Benzamidines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D001550","descriptor_name":"Benzamidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001550","descriptor_name":"Benzamidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006571","descriptor_name":"Heterocyclic Compounds","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D006571","descriptor_name":"Heterocyclic Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0960-894x(01)00029-4","doi":"https://doi.org/10.1016/s0960-894x(01)00029-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0960-894x(01)00029-4","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:11266160","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11266160","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.7246000170707703,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1593430977","https://openalex.org/W1686522130","https://openalex.org/W1989559180","https://openalex.org/W2006194634","https://openalex.org/W2030503717","https://openalex.org/W2038812261","https://openalex.org/W2090786403","https://openalex.org/W2117529142","https://openalex.org/W2266048773","https://openalex.org/W2416743183","https://openalex.org/W2485931422"],"related_works":["https://openalex.org/W2952689347","https://openalex.org/W2084303941","https://openalex.org/W2060334797","https://openalex.org/W2049527791","https://openalex.org/W2020450869","https://openalex.org/W1984625302","https://openalex.org/W2073569452","https://openalex.org/W649163045","https://openalex.org/W4230997406","https://openalex.org/W2000906662"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
